This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Solari, A Articles by Serrati, C Search for Related Content PubMed PubMed Citation Articles by Solari, A Articles by Serrati, C Social Bookmarking                         What's this?

Comparison of two brief neuropsychological batteries in people with multiple sclerosis

solari{at}istituto-besta.it

L Mancuso

A Motta

L Mendozzi

C Serrati

Background: We compared two brief neuropsychological batteries devised to assess people with multiple sclerosis (MS) and used them to assess the relationship between cognitive impairment and clinical characteristics. Methods: We administered either the Brief Repeatable Battery of Neuropsychological Tests (BRBNT) or the Screening Examination for Cognitive Impairment (SEFCI) to 213 consecutive MS outpatients and 213 individually matched controls. Results: Administration times were longer for BRBNT than SEFCI, for MS and controls (p=0.001). People with MS had lower scores in all individual tests than controls (p<0.001, BRBNT and SEFCI). By the criterion of poor performance on one or more tests, the sensitivity of BRBNT was 41.9% and that of SEFCI 31.5%. The corresponding figures by poor performance on two or more tests were 16.2% for BRBNT and 18.5% for SEFCI. The Buschke Selective Reminding and Paced Auditory Serial Addition were the tests best discriminating between people with MS and controls for BRBNT, and the Symbol Digit Modalities test for SEFCI. The only clinical variable independently associated with impaired performance on these batteries was EDSS. Conclusions: Both cognitive batteries were well accepted and easy to administer. Administration time for SEFCI was significantly shorter than for BRBNT; however, alternative forms for serial evaluation are available only for BRBNT. The BRBNT was slightly more sensitive in detecting impairment by the criterion of poor performance on one or more tests. EDSS score was the only clinical variable independently associated with cognitive impairment.

Key Words: cognitive impairment • multiple sclerosis • neuropsychological assessment • outcome measure • screening batteries

Multiple Sclerosis, Vol. 8, No. 2, 169-176 (2002)
DOI: 10.1191/1352458502ms780oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Solari, A. Motta, D. Radice, and L. Mendozzi A shortened version of PASAT-3 is feasible Multiple Sclerosis, September 1, 2007; 13(8): 1020 - 1025. [Abstract] [PDF]

				M P Amato, E Portaccio, B Goretti, V Zipoli, L Ricchiuti, M F De Caro, F Patti, R Vecchio, S Sorbi, and M Trojano The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population Multiple Sclerosis, November 1, 2006; 12(6): 787 - 793. [Abstract] [PDF]

				J Sepulcre, S Vanotti, R Hernandez, G Sandoval, F Caceres, O Garcea, and P Villoslada Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test Multiple Sclerosis, April 1, 2006; 12(2): 187 - 195. [Abstract] [PDF]

				R H. Lazeron, J B Boringa, M Schouten, B M. Uitdehaag, E Bergers, J Lindeboom, M J Eikelenboom, P H Scheltens, F Barkhof, and C H Polman Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis Multiple Sclerosis, October 1, 2005; 11(5): 524 - 531. [Abstract] [PDF]

				M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 519 - 526. [Abstract] [Full Text] [PDF]